Dopamine: What It Is & What It Does

Dopamine is a neurotransmitter in the brain associated with pleasure, reward, motivation, and motor control.

In psychology, dopamine is linked to feelings of gratification and is implicated in mood disorders, addiction, and certain behaviors when its levels are imbalanced.

Function of dopamine

Below are some of the main functions associated with dopamine.

Dopamine does not act in isolation. It works with other neurotransmitters and hormones, such as serotonin and adrenaline, to perform a variety of functions.

1. Pleasure and Reward

Dopamine acts as the brain’s reward chemical that is released during pleasurable experiences, working with the brain’s reward system.

The flood of dopamine that follows a pleasurable stimulus (e.g., delicious food, video games, sex) reinforces the urge to seek it out again. This urge is called “wanting.”

Wanting is not the same as liking. Dopamine drives the motivation to pursue a reward much more than the pleasure of actually getting it (Berridge & Robinson, 1998).

In studies, animals with severely depleted dopamine still enjoyed a sweet taste normally, but stopped working to obtain it.

In classical studies of rats, a surge of dopamine prompts the animal to press a lever to get a pellet of food repeatedly.

Dopamine is also released during the anticipation of reward. This creates powerful reinforcement cycles that encourage us to repeat behaviors that lead to a pleasant experience, making dopamine central to the brain’s reward system.

2. Motivation and Learning

Dopamine plays a role in reward processing, reward prediction, and conditioned learning:

Reward Processing

Dopamine drives goal-directed behavior and decision-making related to rewards. It helps to form crucial associations between our actions and their rewarding outcomes, which enhances our motivation to engage in beneficial activities.

Through this process, dopamine shapes our behavior by influencing how we make choices based on potential rewards.

Reward Prediction

Research has revealed that dopamine neurons demonstrate sophisticated prediction capabilities.

These neurons activate when we encounter unexpected rewards. Over time, they begin responding more strongly to cues that predict the reward rather than the reward itself.

The neurons remain sensitive to whether an expected reward occurs or not, becoming inhibited when an anticipated reward fails to materialize.

The magnitude of potential rewards directly influences dopamine activity, with larger rewards triggering an increased neuronal response.

Conditioned Learning

Dopamine plays a vital role in strengthening associations between stimuli and rewards through conditioned learning.

It enhances our response to cues associated with rewards and is essential for establishing and maintaining conditioned reinforcers.

Dopamine strengthens the associations between actions and their rewards, motivating us to repeat what works and turning those repeated actions into habits.

3. Motor Control

Dopamine is essential for coordinated movement, helps regulate muscle control, and influences balance and posture.

It is critical for initiating voluntary movements and can affect fine motor skills.

Dopamine tunes the basal ganglia’s “go” and “stop” circuits. This lets wanted movements go ahead while suppressing unwanted ones.

When this dopamine supply fails, as in Parkinson’s disease, movement becomes hard to start, slow, and rigid (Romo & Schultz, 1990).

4. Cognitive Functions

Dopamine can enhance focus, attention, and concentration, helping to contribute to executive functioning.

It supports working memory, planning, productivity, and mental alertness for task completion.

For example, if someone has been working hard on a project for a long time, they can experience a surge of dopamine activity when it is finally completed.

Prefrontal dopamine follows an inverted-U pattern. Both too little and too much impair performance; only a well-regulated middle level supports stable, flexible thinking.

This is why stimulant medications, which raise prefrontal dopamine, can sharpen focus in conditions like ADHD.

5. Mood Regulation

Dopamine influences emotional responses and overall mood state, contributing to feelings of well-being.

It works with other neurotransmitters for mood balance and impacts emotional processing and emotional learning.

This shortfall is closely tied to anhedonia. Anhedonia is the loss of interest and pleasure that is a core symptom of depression.

Because dopamine drives the pursuit of reward, a blunted system also reduces the willingness to make an effort, not just the capacity to feel pleasure (Belujon & Grace, 2017).

6. Physiological Functions

Dopamine also has physiological functions such as regulating sleep-wake cycles, and influencing the stress response, and digestive processes.

It can also affect blood flow and can control hormone release, meaning it can module various autonomic functions in the body.

Did you know: Dopamine is a catecholamine, a class of neurotransmitter which also includes epinephrine and norepinephrine.

Where is dopamine found?

Dopamine is highly concentrated in areas of the brain called the substantia nigra and the ventral tegmental area (VTA) in the midbrain. The VTA is a dopamine-rich nucleus located within the midbrain

Other brain areas where dopamine can be made are the hypothalamus and the olfactory bulb.

Dopamine pathways

Dopamine is produced in key midbrain regions and sent to other parts of the brain through four major pathways.

Each pathway connects specific brain structures and supports distinct psychological and physiological functions.

• Mesolimbic pathway: Starts in the ventral tegmental area (VTA) and projects to the nucleus accumbens. This pathway is central to motivation and reward processing.
• Mesocortical pathway: Also originates in the VTA, but projects to the prefrontal cortex, supporting attention, decision-making, and emotional regulation.
• Nigrostriatal pathway: Begins in the substantia nigra and extends to the striatum (caudate and putamen). This system is essential for voluntary movement.
• Tuberoinfundibular pathway: Runs from the hypothalamus to the pituitary gland, where dopamine regulates hormonal balance, particularly prolactin suppression.

These pathways allow dopamine to coordinate activity across brain regions, ensuring that cognition, emotion, movement, and motivation work in harmony.

What happens if you have too much dopamine?

High levels of dopamine can feel euphoric at first. Over time, though, too much can cause real problems.

Excess Dopamine and Addictive Behavior

A surplus of dopamine is linked to more competitive behavior, aggression, poor impulse control, and gambling. Addictive drugs raise dopamine levels, which pushes people to keep using them to chase that rewarding feeling.

This is not limited to drugs. People can become addicted to anything that delivers a surge of dopamine. Video games, food, and social media are common examples.

Stimulant drugs such as cocaine and amphetamine flood the reward pathway directly, by blocking or reversing the transporter that normally clears dopamine away. This produces a rush of dopamine far larger than any natural reward could give (Taylor & Robbins, 1984).

In time, drug cues start grabbing attention on their own. A location, a person, or drug paraphernalia can all pull behavior toward them, the same way an ordinary reward cue does.

Excess Dopamine and Psychosis

Excessive dopamine activity in the mesolimbic pathway, the brain’s reward circuit, is linked to the positive symptoms of schizophrenia, such as hallucinations and delusions (Carlsson, 1988).

Antipsychotic medications that block dopamine receptors help treat these symptoms. Dopamine-enhancing drugs can trigger similar psychotic symptoms in people who do not have schizophrenia.

The evidence for this link is strong. Drugs that raise dopamine, such as high-dose L-DOPA, can trigger psychosis in vulnerable people. Antipsychotics that block the D2 receptor most strongly also tend to work best (Seeman et al., 1976).

The excess is not spread evenly. It sits mainly in the striatum, the brain’s deep movement-and-reward hub. The prefrontal cortex, by contrast, tends to run low on dopamine, which is linked to schizophrenia’s other symptoms rather than the hallucinations and delusions.

What happens if you have too little dopamine?

Low dopamine levels may result in some of the following symptoms:

• Reduced alertness
• Difficulty concentrating
• Motivation difficulties
• Poor coordination
• Movement difficulties
• Reduced pleasurable feelings

In more extreme cases, a lack of dopamine could result in conditions such as Parkinson’s disease, dopamine transporter deficiency syndrome, or depression.

Attention deficit hyperactivity disorder (ADHD) is associated with low levels of dopamine and is associated with difficulties concentrating, paying attention, and impulsivity.

Since people with ADHD have lowered dopamine levels, they are more likely to carry out behaviors in order to obtain more dopamine.

How to manage dopamine levels

Focus on creating a balanced lifestyle that naturally supports healthy dopamine function:

• Maintain consistent daily routines
• Engage in meaningful activities that provide natural rewards
• Build healthy relationships and social connections
• Practice stress management techniques
• Seek professional guidance when needed

When to Seek Help

Consult a healthcare provider if you experience:

• Persistent mood changes
• Significant behavioral shifts
• Difficulty with daily functions
• Signs of addiction or compulsive behaviors
• Movement disorders or coordination problems

Remember that dopamine regulation is highly individual, and what works for one person may not work for another.

Always work with healthcare professionals when making significant changes to your lifestyle or starting any new treatment approach.

Critical Evaluation

The dopamine story is compelling, but a good account weighs it critically. Four criticisms matter most:

1. Not the “Pleasure Chemical”: dopamine is now understood as the currency of wanting and predicting reward, not the direct source of pleasure.
2. The Dopamine Hypothesis Has Limits: it explains hallucinations and delusions well but struggles with schizophrenia’s other symptoms.
3. Correlation, Not Causation: most human evidence comes from brain scans that show a link, not proof that dopamine causes the disorder.
4. One Molecule in a Bigger System: dopamine never acts alone; it works in loops with other brain chemicals and circuits.

Not the “Pleasure Chemical”

Near-total loss of dopamine in animal studies leaves the capacity for pleasure intact. Rats whose dopamine was depleted by up to 99% still showed normal “liking” reactions to a sweet taste (Berridge & Robinson, 1998).

They could still learn new food preferences too.

What they lost was the drive to work for the reward at all. Dopamine, in this view, assigns incentive salience. It makes a reward cue stand out and pulls behavior toward it, rather than producing pleasure itself.

This is why craving for a drug or habit can persist, and even intensify, long after the activity has stopped feeling enjoyable. The “wanting” system stays active even after “liking” fades.

That is the core flaw in the popular “dopamine hit” idea of pleasure.

The Dopamine Hypothesis Has Limits

Antipsychotic drugs occupy and block D2 receptors within hours of the first dose. Full clinical improvement, though, takes weeks (Howes & Kapur, 2009).

That gap suggests something downstream of the receptor block, not the block itself, drives the benefit.

Antipsychotics also help positive symptoms, such as hallucinations, far more than negative or cognitive ones.

So a dopamine-excess account cannot be the whole story. Other systems, especially glutamate, are clearly involved too: blocking NMDA glutamate receptors with drugs like ketamine reproduces a fuller range of schizophrenia’s symptoms (Brisch et al., 2014).

This is why modern models treat dopamine dysregulation as a final common pathway rather than the sole cause. Many risk factors, not one chemical alone, converge on the same endpoint.

Correlation, Not Causation

Most human evidence for dopamine’s role in mental illness comes from brain scans, such as PET and SPECT imaging. These scans are correlational.

A scan can show that a dopamine difference goes along with a disorder. It cannot prove that the difference causes the disorder, rather than resulting from stress, illness, or medication.

The strongest causal evidence instead comes from animal studies. There, researchers can directly lesion or manipulate the dopamine system.

But how well rodent reward circuitry maps onto human conscious experience remains an assumption, not a proven fact.

It is the convergence across species and methods that makes the causal case, not any single scan or study. Human imaging and animal pharmacology point the same way, which is reassuring even if neither proves it alone.

One Molecule in a Bigger System

Pinning complex behavior on “a dopamine imbalance” is tempting, but too simple. Dopamine never acts alone.

It works in loops with glutamate, GABA and serotonin. It also depends on the wider circuitry of the basal ganglia and cortex. What it does at any one synapse depends on the receptor, the pathway, and the state of the whole network.

A single molecule is one node in a system. It is not the seat of a behavior on its own. Explanations pitched purely at the level of dopamine also leave out the psychological and social factors these conditions involve.

None of this erases dopamine’s importance. It just means dopamine works as one part of a larger, interacting system, not a stand-alone explanation for reward, movement, or mental illness.

Contemporary Research

The clearest recent test of the dopamine hypothesis is a 2018 meta-analysis by McCutcheon and colleagues.

• Aim: To find out exactly where in the striatum schizophrenia’s dopamine excess is greatest, testing the long-standing assumption that it sits in the limbic (reward) region.
• Method: A meta-analysis pooled 21 brain-imaging studies of 269 patients with schizophrenia and 313 controls, comparing dopamine activity across the striatum’s three sub-regions.
• Results: Dopamine activity was raised overall, but the increase was strongest in the associative (planning) and sensorimotor regions, not the limbic region the classic theory predicted.
• Conclusion: The dopamine abnormality in schizophrenia sits mainly in the dorsal striatum, not the limbic striatum, which points treatment research toward a new anatomical target (McCutcheon et al., 2018).

The same “wanting” and prediction-error framework used elsewhere in this article is now the shared language researchers use across addiction, depression, and psychosis, rather than one theory per disorder.

It is a sign the field is converging on a shared account of what dopamine actually does, refined by evidence like McCutcheon’s rather than replaced by it.

References

Belujon, P., & Grace, A. A. (2017). Dopamine system dysregulation in major depressive disorders. International Journal of Neuropsychopharmacology, 20(12), 1036-1046.

Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28(3), 309-369. https://doi.org/10.1016/S0165-0173(98)00019-8

Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H. G., Steiner, J., Bogerts, B., Braun, K., Jankowski, Z., Kumaratilake, J., Henneberg, M. & Gos, T. (2014). The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Frontiers in psychiatry, 5, 47.

Bridges, N. (2016, November 25). Dopamine Pathways. Sanesco. https://sanescohealth.com/blog/dopamine-pathways/

Cannon, C. M., Scannell, C. A., & Palmiter, R. D. (2005). Mice lacking dopamine D1 receptors express normal lithium chloride‐induced conditioned taste aversion for salt but not sucrose. European Journal of Neuroscience, 21(9), 2600-2604.

Carlsson, A. (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 1(3), 179-186.

Conrad, B. (n.d.). The Role of Dopamine as a Neurotransmitter in the Human Brain. Enzo. Retrieved 2021, November 5, from: https://www.enzolifesciences.com/science-center/technotes/2018/november/the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/

Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III — the final common pathway. Schizophrenia Bulletin, 35(3), 549-562. https://doi.org/10.1093/schbul/sbp006

Laruelle, M., Abi-Dargham, A., Van Dyck, C. H., Gil, R., D’Souza, C. D., Erdos, J., … & Innis, R. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences, 93(17), 9235-9240.

McCutcheon, R., Beck, K., Jauhar, S., & Howes, O. D. (2018). Defining the locus of dopaminergic dysfunction in schizophrenia: A meta-analysis and test of the mesolimbic hypothesis. Schizophrenia Bulletin, 44(6), 1301-1311. https://doi.org/10.1093/schbul/sbx180

Mosquera, R., Odunowo, M., McNamara, T., Guo, X., & Petrie, R. (2020). The economic effects of Facebook. Experimental Economics, 23(2), 575-602.

Pietrangelo, A. (2019, November 5). How Does Dopamine Affect the Body? Healthline. https://www.healthline.com/health/dopamine-effects

Romo, R., & Schultz, W. (1990). Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. Journal of neurophysiology, 63(3), 592-606.

Schultz, W., Apicella, P., Scarnati, E., & Ljungberg, T. (1992). Neuronal activity in monkey ventral striatum related to the expectation of reward. Journal of Neuroscience, 12(12), 4595-4610.

Seeman, P., Lee, T., Chau-Wong, M., & Wong, K. (1976). Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261(5562), 717-719.

Sepah, C. (2019, August 7). The Definitive Guide to Dopamine Fasting 2.0 – The Hot Silicon Valley Trend. LinkedIn. https://www.linkedin.com/pulse/dopamine-fasting-new-silicon-valley-trend-dr-cameron-sepah/

Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology, 84(3), 405-412.

Taylor, J. R., & Robbins, T. W. (1986). 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology, 90(3), 390-397.

Wise, R. A. (2004). Dopamine, learning and motivation. Nature Reviews Neuroscience, 5(6), 483-494.

Further Reading

• Volkow, N. D., Wang, G. J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., … & Swanson, J. M. (2009). Evaluating Dopamine Reward Pathway in ADHD. JAMA, 302(10), 1084-1091.
• Belujon, P., & Grace, A. A. (2017). Dopamine System Dysregulation in Major Depressive Disorders. International Journal of Neuropsychopharmacology, 20(12), 1036-1046.